Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41598-021-93260-2

http://scihub22266oqcxt.onion/10.1038/s41598-021-93260-2
suck pdf from google scholar
34226622!8257707!34226622
unlimited free pdf from europmc34226622    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34226622      Sci+Rep 2021 ; 11 (1): 13796
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Understanding protection from SARS-CoV-2 using metabolomics #MMPMID34226622
  • Barberis E; Amede E; Tavecchia M; Marengo E; Cittone MG; Rizzi E; Pedrinelli AR; Tonello S; Minisini R; Pirisi M; Manfredi M; Sainaghi PP
  • Sci Rep 2021[Jul]; 11 (1): 13796 PMID34226622show ga
  • The COVID-19 pandemic is still raging in most countries. Although the recent mass vaccination campaign has opened a new chapter in the battle against SARS-CoV-2, the world is still far from herd immunity. There is an urgent need to identify healthy people at high risk of contracting COVID-19, as well as supplements and nutraceuticals that can reduce the risk of infection or mitigate symptoms. In the present study, a metabolic phenotype that could protect individuals from SARS-CoV-2 infection or predispose them to developing COVID-19 was investigated. Untargeted metabolomics was performed on serum samples collected from 51 healthcare workers who were in good health at the beginning of the COVID-19 outbreak in Italy, and who were later exposed to the same risk of developing COVID-19. Half of them developed COVID-19 within three weeks of the blood collection. Our results demonstrate the presence of a specific signature associated with protection from SARS-CoV-2. Circulating monolaurin, which has well-known antiviral and antibacterial properties, was higher in protected subjects, suggesting a potential defensive role against SARS-CoV-2 infection; thus, dietary supplements could boost the immune system against this infection. In addition, our data demonstrate that people with higher levels of cholesterol are at higher risk of developing COVID-19. The present study demonstrates that metabolomics can be of great help for developing personalized medicine and for supporting public healthcare strategies. Studies with larger cohorts of subjects are necessary to confirm our findings.
  • |*Metabolomics[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |COVID-19/epidemiology/*prevention & control[MESH]
  • |Disease Outbreaks/*prevention & control[MESH]
  • |Health Personnel/statistics & numerical data[MESH]
  • |Humans[MESH]
  • |Immunity, Herd/physiology[MESH]
  • |Italy[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box